Olutasidenib
id:
olutasidenib-245-2114818
title:
Olutasidenib
text:
Olutasidenib, sold under the brand name Rezlidhia, is an anticancer medication used to treat relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation. Olutasidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor. It is taken by mouth. The most common adverse reactions include nausea, fatigue/malaise, arthralgia, constipation, leukocytosis, dyspnea, fever, rash, mucositis, diarrhea, and transaminitis. Olutasidenib was approved for medical use in the United States in Decemb
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Olutasidenib
date created:
date modified:
2024-04-05T21:05:39Z
main entity:
{"identifier":"Q76854304","url":"https://www.wikidata.org/entity/Q76854304"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/de/Olutasidenib.svg","width":790,"height":385}
fields total:
13
integrity:
15